| Released | Contributor | Author | Title | Pages | Price |
| 5-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Health Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 5-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| BioMimetic Therapeutics | 6 |
$25 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | BIOMIMETIC THERAPEUTICS INC (BMTI=US) 12-months forecast | 1 |
$15 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | BIOMIMETIC THERAPEUTICS INC (BMTI=US) 2-weeks forecast | 1 |
$10 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | BIOMIMETIC THERAPEUTICS INC (BMTI=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: BIOMIMETIC THERA -- BMTI | 1 |
$4 |
| 3-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMIMETIC THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: BMTI , DYAI , OSIR , SNSS -- DRUGS | 3 |
$4 |
| 1-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for BMTI: the economy's impact on BMTI's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
0.22% Nasdaq 
Research Reports
